Stuart Heminway

Stuart Heminway has over 20 years of experience in regulatory affairs in the pharmaceutical and biotech industry. Stuart is currently serving as the Senior Vice President of Regulatory Affairs at Eidos Therapeutics, a position they have held since January 2022. Prior to this, Stuart was the Vice President and Global Head of Regulatory Affairs at BridgeBio Subsidiary from January 2019 to present. Stuart also worked as the Head of North American Regulatory Affairs at Aimmune Therapeutics from August 2017 to January 2019. Stuart has held various positions in regulatory affairs at MyoKardia, Genentech, Portola Pharmaceuticals, AstraZeneca, and Bristol-Myers Squibb Medical Imaging, where they gained extensive knowledge and expertise in the field.

Stuart Heminway attended Northeastern University, but no specific information regarding the degree or field of study they pursued is available.